One model to account for these data would suggest that regulatory proteins protect cancer cells from the deleterious effects of complement, such as lysis through the MAC complex while allowing the pro-tumorigenic effects mediated by C3a/C5a to act on the TME leading to immunosuppression. This evidence concerns the gene C5 and cancer.